View by year


CONTENTS 2007
We have organized the Content Archive by year. Each year’s list contains all the articles published in that year, organized by category (i.e., Articles, Buzz, Data Mining, Focal Point, Mayday, Recapping The Week, School Zone, Signals vs. Noise, Turn Signals and Trivia). To search by year, click the appropriate link on the left.

Articles Buzz Focal Point Data Mining Mayday
Recapping The Week School Zone Signals vs Noise Turn Signal Trivia

Articles

11/28/2007Personalized Medicine Gets Real
Today, molecular diagnostics stand at the frontier of medical practice. They are already being used to differentiate subjects for clinical trials or help doctors pick the right drug for each patient. And this is just the beginning.


9/28/2007The Perfect Storm
The FDA has been barraged by political, social, economic and regulatory issues this year – but despite the onslaught, it’s managed to stand firm, approving dozens of new drugs, including two "disaster" vaccines (for pandemic flu and smallpox).


8/16/2007The Shifting Sands Of Biotech M&As
Big pharmas have slaked their thirst for biotech drug-makers, at least briefly, choosing instead to fill up on cutting-edge diagnostic and research tool firms. At the same time, other forces are reshaping the M&A landscape, which may never look the same.


7/06/2007Financial Wizards Concoct New Potions
Financiers have brewed up some enchanting options for biotech firms in search of money -- and several alternatives are non-dilutive and nearly risk-free. Are they too good to be true?


5/30/2007Race To Cure HCV Infection Heats Up
Spurred by new insights on HCV’s inner workings, biotechs and big pharmas are jostling for position to win the contest for an effective drug to treat, even cure, this insidious disease. Gentlemen, start your engines.


3/13/2007Banner Year For Biotech Drugs
In 2006, the FDA OK’d a record number of new biotech-derived medicines – some of which represent real breakthroughs in disease prevention and management. They’ve been added to the growing arsenal of cutting-edge therapies that are changing the practice of medicine.


2/04/2007The Rich Get Richer ...
In the topsy-turvy world of biotech financing, investors are sticking with the winners: Firms with robust product sales and promising pipelines attracted enormous amounts of capital in 2006, while many others struggled to raise enough cash to see them through the year.

top

Buzz

11/14/2007Starter Drugs

9/04/2007Reality Check For Biotech’s Best-Sellers

7/13/2007Funding On Track For Record Year

4/21/2007Rough Waters Ahead?

3/16/2007FDA Hits Its Stride

1/24/2007The Class Of 2007
top

Data Mining

6/04/2007Earned Alliance Revenues: Biotechs Reap $22.6B In A Decade Of Deals
top

Focal Point

12/05/2007Stepping Stones

10/17/2007Swinging For The Fences

7/20/2007Mega-Deals Not So Rare Anymore

5/04/2007Navigating The IP Landscape

3/19/2007Allicense 2007: Pick The Winner

2/13/2007Flu Drugs & Vaccines Are Risky Business
top

School Zone

11/16/2007Kudos For Licensing Execs

5/03/2007KGI Cross-Trains Biotech’s Future Leaders

3/23/2007Tech Transfer: The Pipeline Starts Here
top

Signals vs Noise

10/05/2007Financial Snapshot For September 2007: Stocks Getting Stronger

7/10/2007Financial Snapshot For June 2007: Slow But Steady

4/05/2007Financial Snapshot For March 2007: Reversal Of Fortune

1/18/2007Financial Snapshot For December 2006: Steady As She Goes
top

Turn Signals

12/17/2007Blood Cancer Drugs Vie For Attention

10/24/2007Biotech’s Cornucopia Overflowing With Financing Options

8/07/2007Shareholders Flex Their Muscles

6/13/2007ASCO: Tackling Tough Cancers

4/10/2007Alliance Trends: Deal Values Soar

2/24/2007With Blockbusters, The Sky’s The Limit .. Or Is It?

1/06/2007M&As Still Sizzling
top

Trivia

12/26/2007Deck The Halls

12/19/2007Jumping Genes

12/12/2007Swiss-Prot

12/05/2007Old Flies

11/28/2007Catholic Drugs

11/21/2007Hepatocyte Growth Factor

11/14/2007Pucker Up

11/07/2007Founder

10/31/2007Hippocratic Engineering

10/24/2007Drosha & Dicer

10/17/2007National Academies

10/10/2007Asklepios

10/03/2007t.Breeders

9/26/2007Job's Syndrome

9/19/2007Founders

9/12/2007Galactosemia

9/05/2007Lysozyme

8/29/2007Tercica

8/22/2007PKU

8/15/2007Reliant

8/08/2007Usher

8/01/2007Ikaria

7/25/2007Rare Disease

7/18/20073D Structure

7/11/2007Name Game

7/04/2007Christmas In July

6/27/2007ARCA

6/20/2007Alois Alzheimer

6/13/2007TRPping

6/06/2007Amylin Secondaries

5/30/2007Rare Event

5/23/2007Big Toe

5/16/2007Ancient Bug

5/09/2007BIO 2009

5/02/2007First BIO

4/25/2007MCGF

4/18/2007HemoTech

4/11/2007Imaging Name

4/04/2007Pain

3/28/2007Enzyme

3/21/2007Aflatoxins

3/14/2007T Cell

3/07/2007Flamel

2/28/2007Flu Virus

2/21/2007Menkes

2/14/2007Usher Syndrome

2/07/2007Crigler-Najjar

1/31/20071997 Nobel

1/24/2007Unique Virus

1/17/2007Cytokine

1/10/2007JPMorgan

1/03/2007BTK
top


Copyright © 2012. Signals (signalsmag.com) is an online magazine of analysis for biotechnology executives. To contact the Signals editorial department, send e-mail to signals_edit@deloitte.com. Signals is published by: Recap, 2033 N Main Street, Suite 1050 , Walnut Creek, California 94596-3722, Phone: (925) 952-3870